Persisting downward momentum pushes Novartis stock lower
Novartis AG (NVS) stock is trading at $147.78, down 2.06% on the day and ending near the session low. The price has moved below its key short- and medium-term moving averages but remains above its long-term average.
Highlights
- NVS/USD faces persistent selling pressure as price trades below key short- and medium-term moving averages.
- Momentum and oscillator readings indicate a firmly bearish trend with oversold conditions, reinforcing dominant seller control.
- Price is likely to consolidate within the $144.09 to $150.23 range, with a 71% probability of further downside.
Oversold momentum and bearish signals as intraday resistance holds
NVS is trading below both the 20-day ($150.30) and 50-day ($151.00) moving averages, while remaining above the 200-day moving average at $142.14. Immediate resistance is found at the Ichimoku Kijun level of $150.08, with key support at $144.09. The MACD and ADX both reinforce a bearish intraday trend; the Awesome Oscillator indicates a downturn. Momentum oscillators, including RSI, Stoch RSI, CCI, and BBP, are all firmly in oversold territory, confirming persistent seller control.
Downside risk elevated as reversal hinges on key breakout
In the short term, NVS is projected to consolidate within a typical volatility band between $144.09 and $150.23. There is a 29% probability of an upward move and a 71% chance of further downside. A close above $150.08 would be needed to activate a bullish reversal scenario, while a break below $144.09 raises the risk of accelerated selling pressure.
Latest Novartis News
- Forex
- Crypto